T issue injury resulting from ischemia and subsequent reperfusion of an organ or limb is a well-known obstacle in surgery. However, although ischemia by itself induces little damage, reperfusion of the previously ischemic organ with oxygenated blood results in severe tissue destruction. Furthermore, this so-called ischemia/reperfusion injury (IRI) is not necessarily limited to the ischemic organ, but might also involve distant previously not ischemic organs. 1, 2 The underlying mechanisms for the dissemination of IRI remain unclear, although a variety of mediators and processes have been suggested to contribute to this potentially life-threatening condition.
The wash-out of toxic substances from the reperfused organ might be one explanation for the development of multiorgan dysfunction after IRI. 2, 3 This hypothesis is supported by the preferential involvement of organs that receive vast amounts of venous blood such as the liver or lungs. 2, 4 Among the toxic substances that could be distributed with the venous blood from the reperfused organ, reactive oxygen intermediates (ROI) might play a predominant role, because they are generated in vast amounts early in IRI. 5 Further support for the concept of reperfusion-induced oxidative stress as a predominant mechanism in IRI came from the observation of reduced tissue injury after antioxidant treatment. 6, 7 ROI might exert their deleterious effects either by direct reaction with lipids and proteins in biologic membranes or by indirect mechanisms such as impairment of blood flow resulting from platelet activation. [8] [9] [10] Furthermore, ROI-mediated changes of the intracellular redox state have been shown to activate the nuclear transcription factor NF-B/Rel, resulting in increased expression of inflammatory gene products, which might also contribute to the tissue damage. [11] [12] [13] Another important step in the development of IRI is the recruitment and accumulation of polymorphonuclear neutrophils. 3, 4 This recruitment is a multistep process involving adhesion of neutrophils to the vascular endothelium. The "stickiness" of the vascular endothelium, however, relies on the expression of adhesion molecules that can be induced by proinflammatory cytokines. 9 Therefore, the suppression of the inflammatory response seemed to represent one treatment option in IRI, and the administration of antiinflammatory cytokines (eg, IL-10) has been suggested to minimize the inflammatory response and the spreading of IRI to distant organs. 14 However, there is evidence that the inflammatory response might as well be necessary for the recovery of the organism after IR or sepsis. 15 The recovery might involve the activation of endogenous protective mechanisms such as the inducible stress protein heme oxygenase-1 (HO-1). 2, 16, 17 HO-1 possesses potent antioxidant capacities and thus might act as protective antiinflammatory protein in oxidative stressinduced injury. 18 Accordingly, an increased expression of HO-1 has been observed during inflammatory processes. 19 Another protective molecule in IRI might be nitric oxide (NO), even though deleterious effects of NO in inflammatory processes have been observed. 20 NO is produced in large amounts after induction of the inducible nitric-oxide-synthase (NOS-2) by proinflammatory cytokines. 21, 22 The beneficial effects of NO include inhibition of neutrophil infiltration and improvement of microcirculation resulting from the vasodilatory effect of NO. 9, 10, 23, 24 Furthermore, NO might provide protection against oxidative stress through neutralization of ROI 10,21 and induction of HO-1. 19 The requirement of proinflammatory cytokines for the induction of endogenous potentially protective mechanisms such as the expression of HO-1 or NOS-2 questions the effectiveness of antiinflammatory cytokines in the treatment of IRI.
Consequently, this study provides evidence not only for the dissemination of oxidative stress into the liver in selective intestinal IRI, but also for a beneficial effect of the proinflammatory cytokine IL-2 and a negative effect of IL-10 on IRI. The administration of IL-2 resulted in the activation of NF-B/Rel, and subsequently in increased NOS-2 expression in the intestine and liver, as well as increased NO production. In contrast, the administration of IL-10 failed to improve the outcome in IRI. The negative effect of IL-10 could be attributed to diminished NF-B/Rel activation and subsequently reduced NOS-2 mRNA expression and NO production.
MATERIALS AND METHODS

Experimental Procedures
Male Lewis rats weighing 250 to 300 g were acclimated for at least 1 week on a 12:12 hour light-dark cycle with free access to standard rodent chow and water. The study was performed in accordance with the National Guidelines for the Use and Care of Laboratory Animals and was approved by the local animal care and use committee. Rats were anesthetized with Ketamine (100 mg/kg body weight) and Xylazine (5 mg/kg body weight) intramuscularly and placed in a supine position. The abdominal cavity was accessed by a midline incision and the superior mesenteric artery (SMA) was visualized. The SMA was clamped selectively avoiding impairment of the hepatic artery or the portal vein. Pulselessness of the mesentery and visible loss of intestinal perfusion was achieved immediately after complete occlusion of the SMA. Five minutes before reperfusion all animals received an intravenous injection of either vehicle (1 mL of NaCl 0.9% supplemented with 1% rat serum), IL-2 (40 g/kg body weight) or IL-10 (40 g/kg body weight) through the penis vein. After 60 minutes of intestinal ischemia, the clamp was removed and the midline incision was closed. Depending on the observation period, rats were kept under anesthesia or were allowed to recover from anesthesia and placed back into their cages with free access to food and water. At the time points indicated, the rats were exsanguinated under anesthesia by aortal puncture. Serum samples were obtained for determination of hyaluronic acid (HA), amino-aspartate transaminase (AST), and nitrite/nitrate (NO 2 Ϫ /NO 3 Ϫ ) concentrations. Intestinal (jejunum) and hepatic tissue samples were harvested and separately processed for the determination of total glutathione (GSH) tissue levels as well as for the extraction of RNA for RT-PCR experiments assessing the expression of inducible NO synthase (NOS-2) or heme oxygenase-1 (HO-1). Nuclear extracts from the tissue specimens were used for the analysis of NF-B/Rel activation using an electrophoretic-mobility shift assay (EMSA).
Experimental Groups
Rats were randomly assigned to the different experimental groups. The sham-operated animals (control, n ϭ 6) were anesthetized, the abdominal cavity was opened by a midline incision, and the SMA was visualized. No clamp was positioned, the abdomen was closed, and the animals were killed. All animals in the ischemia-reperfusion group (IRI, n ϭ 20) were subjected to 60 minutes of intestinal ischemia and received 1 mL of vehicle 5 minutes before the end of ischemia. Animals were killed directly after ischemia or after 1 hour, 4 hours, and 24 hours of reperfusion time. All animals in the interleukin-2 group (IL-2 group, n ϭ 20) were subjected to 60 minutes of intestinal ischemia and received 40 g/kg of IL-2 (in a volume of 1 mL of vehicle) 5 minutes before the end of ischemia. Animals were killed after 1 hour, 4 hours, and 24 hours of reperfusion time. All animals in the interleukin-10 group (IL-10 group, n ϭ 20) were subjected to 60 minutes of intestinal ischemia and received 40 g/kg of IL-10 (in a volume of 1 mL of vehicle) 5 minutes before the end of ischemia. Animals were killed after 1 hour, 4 hours, and 24 hours of reperfusion time. 
Measurement of Serum Concentrations of
Determination of Total GSH Tissue Levels
Samples for the determination of tissue concentrations of GSH and total protein concentrations were snap frozen in liquid nitrogen immediately after excision and were stored at -80°C until analysis. Total GSH (representing GSH ϩ GSSG) was assayed by a modified method reported by Griffith 26 using an enzymatic recycling procedure in which reduced GSH was sequentially oxidized by 5,5'-dithiobis-(2-nitrobenzoic-acid) (DTNB) to GSSG which is then reduced by NADPH back to GSH in the presence of glutathione reductase to react again with DTNB. 27 The rate of DTNB formation is monitored at 412 nm and the glutathione concentration was determined using a standard curve. All data were normalized per milligram of protein.
Analysis of Gene Expression by RT-PCR
For the detection of NOS-2 and HO-1 by RT-PCR, total RNA was extracted from liver and intestinal tissue samples using the single-step method of Chomczynski and Sacchi. 28 Then, 2 g of total RNA were reversely transcribed into cDNA in a total volume of 10 L in 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 4 mM MgCl2, 1.0 mM of each dNTP, 10 mM DL-dithiothreitol, 10 U of human placental RNase inhibitor, oligo (dT) primers, and 200 U of SUPERSCRIPT II TM reverse transcription (all Gibco BRL Life Technologies, USA) at 37°C for 60 minutes. The reaction mixture was then diluted to a final volume of 20 L of which 2 L was further subjected to PCR. Amplification of an 499-bp and 254-bp product was carried out with NOS-2-and HO-1-specific primers as previously described 10, 29 in a total volume of 20 L containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 200 M each dNTP, 1.5 mM MgCl2, and 1 U of Taq DNA polymerase (all Gibco/BRL, Life Technologies) for 35 cycles of 35 seconds at 96°C (denature), 2 minutes at 56°C (anneal-ing), and 2 minutes at 72°C (extension). ␤-actin was used as an internal standard in each experiment for confirmation of equal loading. PCR products were electrophoresed on 1.5% agarose gels containing 0.1 g ethidium bromide and photographed under UV transillumination.
Quantification of Gene Expression by Real-time PCR
The expression of each gene transcript in liver and gut biopsies was analyzed by real-time PCR using the ABI PRISM 7700 Sequence Detection System (TaqMan). 30 The method uses the 5' nuclease activity of Taq polymerase to cleave a nonextendable hybridization probe during the extension phase of the polymerase chain reaction (PCR). The approach uses dual-labeled fluorogenic hybridization probes. One fluorescent dye serves as a reporter (FAM, 6-carboxyfluorescein) and its emission spectrum is quenched by the second fluorescent dye (TAMRA, 6-carboxy-tetramethylrhodamine). The reactions were monitored in real time during the log phase of product accumulation. The cycle number at which the amplification plot crosses a fixed threshold above baseline is defined as the threshold cycle (C t ). cDNA variations across different samples were normalized using rat beta-actin-specific primers. Briefly, DNase digestion was performed before cDNA synthesis to avoid amplification of cross-reacting genomic DNA. Gene profiles were analyzed for the rat HO-1 and NOS-2 genes. Relative quantification was performed using the comparative ⌬Ct method by Perkin-Elmer. The mean Ct values for ␤-actin and the study samples were calculated from double determinations and expressed as a unitless value according to the formula 2 -⌬Ct . The exact condition for the real-time PCR were as follows: each reaction was performed in a final volume of 25 L containing 1 L cDNA, 12.5 L Master Mix (TaqMan Universal PCR Master Mix, Perkin Elmer, Applied Biosystems, Weiterstadt, Germany), 1 L hybridization probe, 6 L primer mix, and 5.5 L distilled water. After an initial step of 2 minutes at 50°C involving activation of uracyl-n-glycosylase and degradation of any preexisting contaminating RNA sequences, denaturation and a hot start for Amplitaq Gold DNA polymerase was performed at 95°C for 10 minutes. The amplification took place in a two-step PCR (40 cycles; 15-sec denaturation step [95°C] and 1 min annealing/extension step [60°C]).
Analysis of Hepatic and Intestinal NF-B/Rel Binding Activity
The NF-B/Rel binding activity was analyzed by EMSA. Nuclear protein extracts for EMSA were prepared as described by Steinle et al. 31 Tissue samples were homogenized in sucrose buffer (2.1 M) containing 1 mM MgCl 2 , 10 mM HEPES, 5 mM NaF, 0.1 mM PMSF, 0.5 mM Leupeptin, 0.5 mM Pepstatin, 5 mM Aprotinin, 1 mM DTT, and nuclei 
Statistics
All values are presented as mean Ϯ standard error of mean (SEM). Variables were tested for group differences with the Wilcoxon rank sum test or the Student's t test if the variables were normally distributed. In all instances, P Ͻ 0.05 was considered significant.
RESULTS
Modulation of Intestinal Ischemia With IL-10 Increases Intestinal and Hepatic Tissue Injury
Intestinal and hepatic tissue injury after selective intestinal ischemia were determined by analyzing the serum concentrations of HA and aspartate-aminotransferase AST ( Table 1 ). Intestinal ischemia resulted in a slight but significant increase of AST levels, whereas the circulating levels of HA remained unchanged. Reperfusion of the ischemic intestine led to an additional significant increase of serum levels of AST and HA with a peak 24 hours after reperfusion ( Table 1) .
Animals receiving IL-2 before reperfusion displayed significantly lower HA serum levels, but not AST levels, when compared with untreated animals (IRI group) ( Table 1) . In contrast, the administration of IL-10 resulted in significantly increased serum concentrations of AST and HA when compared with untreated or IL-2-treated rats ( Table 1 ).
Modulation of Intestinal Ischemia With IL-10 Results in Increased Oxidative Stress in the Intestines
The next experiments were performed to determine whether oxidative stress (which was assessed by the reduction of intracellular glutathione) was associated with intes- tinal and hepatic tissue destruction after intestinal IRI ( Table 2) . IRI resulted in significantly decreased GSH concentrations in both organs. In the intestines, the reduction of GSH was detectable only during the first hour after reperfusion, whereas in the liver a significant reduction of GSH was detectable up to 4 hours after reperfusion. In the liver, IL-2 and IL-10 administration did not result in alterations of the GSH concentrations when compared with untreated animals (IRI group) ( Table 2 ). In the intestines, a different pattern was observed. IL-2-treated rats displayed significantly lowered intestinal GSH levels 24 hours after reperfusion when compared with untreated rats (IRI group). In contrast, the administration of IL-10 resulted in a profound reduction of intestinal GSH levels at all time points ( Table 2 ).
Modulation of Intestinal Ischemia With IL-2 Results in Increased mRNA Expression of the Inducible Heme Oxygenase-1 in the Intestines
Protection against ischemia reperfusion injury might be mediated through stress proteins such as heme oxygenase-1. 2, 18 The next experiments were performed to determine whether IRI was associated with an increased expression of HO-1. IRI resulted in significantly increased HO-1 mRNA expression in the intestines and liver up to 24 hours after reperfusion (Fig. 1) . The administration of IL-2 before reperfusion provoked an additional significant increase of HO-1 mRNA expression in the intestines 1 hour after reperfusion, whereas the hepatic HO-1 mRNA expression was not altered. IL-10 administration also failed to alter the HO-1 mRNA expression in the liver, but resulted in a significantly dimin-ished intestinal HO-1 mRNA expression when compared with IL-2-treated animals (Fig. 1 ).
Modulation of Intestinal Ischemia With IL-2 Induces Increased mRNA Expression of the Inducible NO-synthase
The expression of NOS-2 has been associated with beneficial and detrimental effects in inflammatory processes. 9, 20, 23, 24 To determine whether modulation of IRI by IL-2 or IL-10 was associated with altered expression of NOS-2, quantitative PCR analysis of NOS-2 mRNA expression in the small intestines and liver was performed (Fig. 2) . As described previously, a constitutive NOS-2 mRNA expression was detected in the small intestines in control animals, 33 whereas such constitutive NOS-2 mRNA expression could not be detected in the livers of the same rats. Intestinal ischemia resulted in increased intestinal and hepatic NOS-2 mRNA expression as early as 1 hour after reperfusion. Within 24 hours after reperfusion, the NOS-2 mRNA expression in both organs returned to baseline levels (Fig. 2) . The administration of IL-2 resulted in an additional significant increase of NOS-2 mRNA expression in both organs up to 24 hours after reperfusion. In contrast, IL-10 administration resulted in a brief and less pronounced increase of NOS-2 mRNA expression only 1 hour after reperfusion.
Modulation of Intestinal Ischemia With IL-2 Results in Increased Serum Concentrations of Nitrite and Nitrate
To determine whether the increased NOS-2 expression was also associated with an increased production of NO, the Ϫ were analyzed (Table 3) . IRI resulted in a significant increase of NO 2 Ϫ /NO 3 Ϫ serum levels with a peak 4 hours after reperfusion. The administration of IL-2 resulted in an additional significant increase of NO 2 Ϫ /NO 3 Ϫ serum concentrations 4 hours after reperfusion. In contrast, the animals that received IL-10 lacked a significant increase of NO 2 Ϫ /NO 3 Ϫ serum levels. In these animals, the NO 2 Ϫ /NO 3 Ϫ serum concentrations were even lower than in the untreated rats.
NF-B/Rel Binding Activity Is Increased After Selective Intestinal Ischemia Reperfusion
NF-B/Rel plays an important role in the transcriptional regulation of various gene products of the inflammatory response. 11, 13 The next experiments were performed to analyze whether the altered expression of HO-1 and NOS-2 after IRI was associated with alterations of the NF-B/Rel activity in the intestines and liver (Fig. 3 ). Sham operation (control animals) or intestinal ischemia without reperfusion did not lead to increased NF-B/Rel activity, whereas ischemia and reperfusion resulted in increased NF-B/Rel activity. In the intestines, NF-B/Rel activity peaked 4 hours after reperfusion, whereas in the liver the peak of NF-B/Rel activity could be observed 1 hour after reperfusion. In both organs, the NF-B/Rel activity returned to baseline levels within 24 hours after reperfusion. The competition assay using an excess of unlabeled B probe demonstrated the specificity of the signal.
Administration of IL-2 resulted in an additional significant increase of NF-B/Rel activity in both organs. Interestingly, the time course of NF-B/Rel activity differed between the 2 organs. In the liver increased NF-B/Rel activity was detectable only during the first hour after reperfusion, whereas in the intestines increased NF-B/Rel activity was observed up to 24 hours after reperfusion. In contrast, IL-10 administration failed to increase intestinal or hepatic NF-B/ Rel activity at any time point when compared with untreated animals.
DISCUSSION
A variety of surgical diseases such as arterial embolism are characterized by an intermittent interruption of blood supply. Reestablishment of the blood flow is an essential condition of tissue survival, but reperfusion is also associated with tissue injury in the involved organ and can lead to systemic life-threatening complications. [1] [2] [3] Despite the welldocumented clinical consequences of IRI, successful therapeutic or preventive strategies are still missing.
A variety of factors have been identified to contribute to the tissue injury in IRI, of which ROI as well as the expression of adhesion molecules and subsequent recruitment of Annals of Surgery • Volume 238, Number 1, July 2003 Negative Effect of IL-10 on Ischemia/Reperfusion Injury neutrophils seem to be most important. [3] [4] [5] [6] Therefore, antioxidants, antiinflammatory agents, and cytokines have been proposed to be useful for the prevention of IR-related tissue injury. 7, 14 Based on these reports, the effects of the antiinflammatory cytokine IL-10 and the proinflammatory cytokine IL-2 on tissue injury after selective intestinal ischemia were compared in the present study. To mimic the clinical situation of acute intestinal ischemia, the cytokines were administered in a model of warm intestinal ischemia at the end of the ischemic period before reperfusion. Using this model, selective intestinal ischemia resulted in tissue injury not only in the intestines, but also in the liver, which is in agreement with earlier reports. 1, 3, 5, 34, 35 The administration of cytokines showed 2 surprising results. IL-10, an antiinflammatory cytokine, did not ameliorate tissue injury, but resulted in increased tissue injury in the intestines and liver, whereas administration of the proinflammatory cytokine IL-2 led to decreased tissue injury in the intestine but had little effect on the liver. These results question the hypothesis of a beneficial role of antiinflammatory agents in IRI. 14 One of the possible mechanisms of tissue injury in IRI which could have been targeted by the administration of cytokines is oxidative stress. 4 -6 In this study, oxidative stress was assessed by alterations of GSH. 36, 37 The reduction of GSH tissue levels in the intestines and liver within the first hour after intestinal IRI pointed toward the release of ROI in both organs early after selective intestinal IRI. 6, 7 The detrimental effect of IL-10 was associated with significantly decreased GSH levels in the intestines, suggesting alterations of the cellular redox state. In the liver, however, the increased tissue injury after IL-10 administration was not accompanied by a decrease of GSH levels. Furthermore, the administration of IL-2 remained without effect on the tissue levels of GSH, indicating that the beneficial effect of IL-2 could not be attributed to decreased oxidative stress.
We then investigated the hypothesis of whether IL-2 might initiate endogenous protective mechanisms, whereas IL-10 might inhibit such mechanisms, including NOS-2 and/or HO-1. 2, 18, 38 In accordance with this hypothesis we were able to demonstrate increased NOS-2 mRNA expression in the intestines and liver as well as increased systemic NO production after intestinal IRI, which was further enhanced by IL-2 administration. In contrast, IL-10 failed to enhance NOS-2 activity, an observation that points toward a beneficial effect of NO in IRI. This hypothesis was further supported by our observation that IL-10 failed to increase the serum con-
In fact, the NO 2 Ϫ /NO 3 Ϫ levels after IL-10 treatment were even lower than in untreated rats, suggesting an inhibitory effect of IL-10 on NOS-2 activity after IRI. This hypothesis of an inhibitory effect of IL-10 on NO production is in accordance with an earlier study 38 reporting about increased NO production in airway cells of IL-10 knockout mice. One explanation for the proposed beneficial role of NO in IRI relies on the hypothesis that NO might modulate the cellular adaptation to stress situations through activating endogenous antioxidant defense systems such as HO-1, 19 which has been shown to be protective in models of inflammation. 17, 18, 39 The protective effect of increased HO-1 expression is probably mediated by purging heme iron, a potent catalyst of oxidant injury, from the cells 11) . IRI, animals undergoing ischemia and reperfusion without cytokine treatment; IRIϩIL-2 or IRIϩIL-10, animals receiving interleukin-2 (40 g/kg) or interleukin-10 (40 g/kg) intravenously 5 minutes before reperfusion. Competition assays (lanes [12] [13] [14] [15] were performed with excess of labeled B probe (10-, 50, and 100-fold).
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Annals of Surgery • Volume 238, Number 1, July 2003 and by the production of bilirubin, an effective antioxidant and inhibitor of leukocyte adhesion. 39 In accordance with this hypothesis, we were able to demonstrate an increased expression of HO-1 mRNA after selective intestinal IRI in the intestines and liver. The administration of IL-2 led to an additional significant increase of HO-1 expression, whereas IL-10 did not result in increased expression of HO-1 mRNA. These results suggest a beneficial effect of increased HO-1 mRNA expression in the intestines after IRI.
Our observations indicate that alterations of NOS-2 expression, NO production, and HO-1 expression might mediate the controversial effects of IL-2 and IL-10 on intestinal IRI. Because NO has been shown to be capable of inducing HO-1 expression, it is conceivable that the increased systemic release of NO might have influenced HO-1 expression in IRI. GSH depletion has also been shown to induce HO-1 mRNA expression. 40 In our study, however, a significant decrease of intestinal GSH levels after IL-10 administration was not associated with increased HO-1 mRNA expression. Based on this observation, we consider the regulatory effects of GSH depletion on HO-1 expression rather small during the early phase of reperfusion in our model of intestinal IRI. Our results of a parallel induction of NOS-2 and HO-1 activity after intestinal IRI, as well as a parallel increase of mRNA expression of both genes after IL-2 administration, suggest a regulatory mechanism further upstream. Both NOS-2 and HO-1 genes contain transcription factor recognition sites for NF-B/Rel. 13, 41 Our observations of increased NF-B/Rel activity in the intestines and liver after IL-2 administration and decreased NF-B/Rel activity after IL-10 administration point toward a regulatory role of NF-B/Rel in the expression of NOS-2 and HO-1 mRNA after intestinal IRI.
In conclusion, this study provides evidence for a beneficial effect of IL-2 and a detrimental effect of IL-10 on IRI after selective intestinal ischemia. The underlying mechanisms of these effects rely on alterations of NOS-2 and HO-1 expression and NF-B/Rel activation rather than on alterations of oxidative stress.
